Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of TBI+Fludarabine vs TLI+ATG Conditioning for Allo-HCT
NCT00603954Phase 2Completed
- Sponsor
- University of Liège
- Start
- Jan 2008
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of antithymocyte globulin rabbit in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML) and 6 more (2 arms), sponsored by University of Liège. Primary endpoint: Percentage of Participants With Grade II-IV Acute GVHD at 180 days. Started Jan 2008; status: completed.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)myeloproliferative neoplasms (MPN)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00603954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603954.